Provider Perspectives to Inform a Patient‐Facing Decision Aid on Oral Corticosteroid Use During Pregnancy and Evaluation of the Aid

PURPOSE: We previously identified patient need for a decision aid on oral corticosteroid (OCS) use during pregnancy that could be used to support discussions between providers and patients. In the current study, we aimed to identify healthcare provider needs for a decision aid on OCS use during pregnancy and then evaluated the usefulness of the decision aid that we developed. METHODS: Before developing a decision aid on OCS use during pregnancy, we conducted semi-structured interviews with providers from one health system to understand needs for an aid for counseling patients about OCS use during pregnancy. To assess the usefulness of the decision aid that we developed, providers reviewed the decision aid and responded to survey questions. Also, the survey assessed provider knowledge regarding counseling on OCS use during pregnancy before and after reviewing the aid (knowledge scores range 0-15). RESULTS: In interviews, all providers (n = 13) reported that a patient-facing decision aid would be useful when discussing OCS use during pregnancy because it would give information to patients and providers, and it would facilitate decision making. Among the providers who participated in the survey (n = 68), two-thirds reported after reviewing the aid that they would usually or always use the decision aid in conversations about OCS treatment during pregnancy. All survey participants reported that they would recommend the decision aid to colleagues. Overall, providers' median knowledge score improved by 1 (IQ range 3) after reviewing the decision aid (p < 0.01). CONCLUSIONS: We established the usefulness of a decision aid on OCS use during pregnancy for providers.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2026-06-17
DOI
https://doi.org/10.1002/pds.70413
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Provider Perspectives to Inform a Patient‐Facing Decision Aid on Oral Corticosteroid Use During Pregnancy and Evaluation of the Aid

Jeanette Y. Ziegenfuss, Christina Chambers, Meghan M. JaKa, Lyndsay A. Avalos et al.
Pharmacoepidemiology and Drug Safety
Pregnancy and Medication Impact
article

Provider Perspectives to Inform a Patient‐Facing Decision Aid on Oral Corticosteroid Use During Pregnancy and Evaluation of the Aid

Jeanette Y. Ziegenfuss, Christina Chambers, Meghan M. JaKa, Lyndsay A. Avalos, Elyse O. Kharbanda, Kristin Palmsten, Gabriela Vazquez‐Benitez, Elisabeth A. Seburg
article en

Abstract

PURPOSE: We previously identified patient need for a decision aid on oral corticosteroid (OCS) use during pregnancy that could be used to support discussions between providers and patients. In the current study, we aimed to identify healthcare provider needs for a decision aid on OCS use during pregnancy and then evaluated the usefulness of the decision aid that we developed. METHODS: Before developing a decision aid on OCS use during pregnancy, we conducted semi-structured interviews with providers from one health system to understand needs for an aid for counseling patients about OCS use during pregnancy. To assess the usefulness of the decision aid that we developed, providers reviewed the decision aid and responded to survey questions. Also, the survey assessed provider knowledge regarding counseling on OCS use during pregnancy before and after reviewing the aid (knowledge scores range 0-15). RESULTS: In interviews, all providers (n = 13) reported that a patient-facing decision aid would be useful when discussing OCS use during pregnancy because it would give information to patients and providers, and it would facilitate decision making. Among the providers who participated in the survey (n = 68), two-thirds reported after reviewing the aid that they would usually or always use the decision aid in conversations about OCS treatment during pregnancy. All survey participants reported that they would recommend the decision aid to colleagues. Overall, providers' median knowledge score improved by 1 (IQ range 3) after reviewing the decision aid (p < 0.01). CONCLUSIONS: We established the usefulness of a decision aid on OCS use during pregnancy for providers.

Pharmacoepidemiology and Drug SafetyVol. 35(7)
Kaiser Permanente (US), University of California San Diego (US), HealthPartners (US)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Peace, Justice and strong institutions
Openalex Percentile: Top 6%
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.